Language Selection En
Contact Us
Contact Us
Contact Us
Product Information for Physicians

Bulkamid

Bulkamid is a urethral bulking system containing a water-based biocompatible hydrogel that may be considered in selected female stress urinary incontinence treatment pathways following specialist physician evaluation.

  • Urethral bulking system containing a water-based hydrogel
  • Minimally invasive application approach
  • Application intended to support urethral coaptation
  • Evaluation within female stress urinary incontinence treatment pathways
  • Patient selection based on specialist physician evaluation
Request Technical Information Review Application Process Support
Bulkamid

Verified Product Information

Professional information on product identity, system structure, and use framework.

01

Product Supply

Product and logistics coordination planned around the institution's defined need.

02

Process Preparation

Product and process preparation aligned with the plan defined by the clinical team.

03

Technical Documentation

Support for current technical information, instructions for use, and professional resource requests.

04
Product support process
Bulkamid
Product Overview

A minimally invasive urethral bulking approach for specialist physician evaluation

Bulkamid is a urethral bulking system containing a water-based hydrogel that may be considered in selected cases of female stress urinary incontinence following specialist physician evaluation.

The hydrogel is placed in the urethral wall to support urethral coaptation. Product suitability, potential benefits, limitations, alternative treatments, and follow-up requirements should be evaluated for each patient.

Luvi Health provides verified product information, product supply, current technical documentation, and application preparation coordination in line with the clinical team's plan. Diagnosis, product selection, application, and treatment decisions remain with the specialist physician.

Bulkamid System Structure

System components and technical functions supporting controlled delivery of the Bulkamid hydrogel

Bulkamid system component Bulkamid control component Bulkamid reservoir component Bulkamid connection component Bulkamid complete system

01

Hydrogel Structure

Water-based biocompatible bulking agent composition.

02

Application System

Delivery mechanism designed for controlled injection.

03

Application Approach

System structure supporting controlled delivery of the hydrogel.

04

Urethral Coaptation Support

Structure intended to support continence management mechanisms.

05

Complete System

All components work together to create an integrated, functional, and engineering-focused system structure.

Why Luvi Health?

Luvi Health support for product preparation and process coordination

01   Alignment with the Clinical Plan

The preparation scope is clarified according to the treatment plan and product requirements defined by the clinical team.

02   Product and Supply Preparation

Product supply, application requirements, and current technical documentation are coordinated before the procedure.

03   Application Process Coordination

Technical coordination aligned with the application workflow may be provided when required; clinical decisions and application responsibility remain with the physician.

04   Documentation and Follow-Up

Communication continues for product-related technical questions and documentation needs.

Technical Information

Key technical considerations for Bulkamid evaluation

This content provides general professional product information. Current official instructions for use and specialist physician evaluation must guide patient selection, indications, contraindications, warnings, application technique, and follow-up.

  • 01 Hydrogel Structure

    The product contains a water-based biocompatible hydrogel as defined in the current technical documentation.

  • 02 Minimally Invasive Application

    The hydrogel is placed in the urethral wall using a controlled injection approach.

  • 03 Urethral Coaptation

    The application is intended to support urethral coaptation.

  • 04 Application System

    The delivery system and procedural steps should be evaluated according to the current official instructions for use.

  • 05 Clinical Use Area

    Bulkamid may be considered in selected female stress urinary incontinence treatment pathways.

  • 06 Patient Suitability

    Product suitability is determined according to clinical condition, treatment goals, alternatives, and specialist physician evaluation.

  • 01 In which treatment area is Bulkamid evaluated?

    Bulkamid may be evaluated in selected female stress urinary incontinence treatment pathways as a minimally invasive urethral bulking option.

  • 02 How can information about Bulkamid application be requested?

    Application-related information should be evaluated through official product documentation and specialist physician assessment. Healthcare professionals may contact Luvi Health for product-related information.

  • 03 Is support available for physicians using Bulkamid?

    Yes. Product information, application process guidance, and technical support may be provided for physicians and qualified healthcare professionals.

Frequently Asked Questions

Bulkamid frequently asked questions

Answers to common questions about Bulkamid, product use, and technical support.

For Healthcare Professionals

Request verified product information and application process support for Bulkamid

Contact Luvi Health for product supply, current technical documentation, and application preparation aligned with the clinical team's plan.
Request Professional Support
Send message